Press release
United States Charcot-Marie-Tooth Disease Market to Grow at 5.8% CAGR, Led by Neurogene, Pharnext, and Affectis Pharmaceuticals | DataM Intelligence
Charcot-Marie-Tooth Disease Market
United States: Recent Industry Developments
✅ In October 2025, Neurogene Inc. received FDA Orphan Drug Designation for its novel gene therapy targeting CMT1A, moving into Phase III clinical trials.
✅ In October 2025, the National Institutes of Health (NIH) allocated USD 45 million for CMT research focusing on genetic therapies and biomarker development.
✅ In October 2025, Addex Therapeutics launched a pivotal Phase IIb trial for its small molecule therapy addressing neuropathic pain in CMT patients.
Europe: Recent Industry Developments
✅ In October 2025, Pharnext S.A. announced positive topline results from its PREMIER trial of PXT3003 for CMT1A treatment in European patients.
✅ In October 2025, the European Medicines Agency granted Priority Medicines (PRIME) designation to Affectis Pharmaceuticals' CMT treatment candidate.
✅ In October 2025, Lupin Limited entered a strategic partnership with a European biotech to develop and commercialise novel CMT therapies across EU markets.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/charcot-marie-tooth-cmt-disease-market?jd
Market Trends & Drivers
The Charcot-Marie-Tooth Disease Market is experiencing significant growth driven by increasing disease awareness, advancements in genetic research, and growing investment in orphan drug development. Key trends include the emergence of gene therapies, development of targeted symptom management, and expansion of patient registries for clinical trial recruitment. The improving diagnostic capabilities, orphan drug incentives, and collaborative research initiatives are significantly accelerating market development.
Competitive Landscape
The market features specialized competition among biotechnology companies, pharmaceutical firms, and research organizations focusing on rare neurological diseases.
✦ Neurogene Inc. leads in gene therapy development for CMT and related inherited peripheral neuropathies.
✦ Pharnext S.A. pioneers combination therapy approaches with its lead candidate PXT3003 for CMT1A.
✦ Affectis Pharmaceuticals AG focuses on novel molecular targets for CMT treatment and symptom management.
✦ Addex Therapeutics Ltd. develops allosteric modulators for neuropathic pain in CMT patients.
✦ Lupin Limited expands its neurology portfolio with CMT therapeutic candidates and diagnostic tools.
✦ DTx Pharma Inc. advances RNA-based therapeutics for various CMT subtypes.
✦ Viking Therapeutics Inc. explores metabolic modulators for CMT-related muscle weakness and fatigue.
✦ StrideBio Inc. develops novel capsids for gene therapy delivery in CMT and other neurological disorders.
✦ Taysha Gene Therapies Inc. focuses on AAV-based gene therapies for monogenic neurological diseases, including CMT.
✦ Applied Genetic Technologies Corporation (AGTC) develops gene therapies for inherited diseases, including certain CMT subtypes.
Segmentation
By Disease Type (CMT1, CMTX, CMT4, CMT2, Others)
By Treatment Type (Physical Therapy, Occupational Therapy, Orthopedic Devices, Others)
By End-User (Hospitals, Specialty Clinics, Home Care Settings, Others)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/charcot-marie-tooth-cmt-disease-market?jd
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (Germany, U.K., France, Italy, Spain, Rest of Europe)
⇥ Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia Pacific)
⇥ South America (Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us:
DataM Intelligence is a market research and consulting firm that bridges the gap between data and decisive action. We specialise in translating top market trends and in-depth analysis into swift, smart solutions for your business.
With a repository of 6,300+ reports across 40+ industries, we provide the robust intelligence that over 200 companies in 50+ countries rely on to power their growth.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Charcot-Marie-Tooth Disease Market to Grow at 5.8% CAGR, Led by Neurogene, Pharnext, and Affectis Pharmaceuticals | DataM Intelligence here
News-ID: 4246667 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Clinical Trial Management System Market Set for Strong Growth to USD 4.2 Billion …
The Global Clinical Trial Management System Market reached USD 1.5 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 4.2 billion by 2031. The global clinical trial management system market is expected to exhibit a CAGR of 14.6% during the forecast period (2024-2031).
Market growth is driven by the rising complexity of clinical trials, increasing R&D investments by pharmaceutical and biotech companies, and the need…
Femtech Market US$ 112.30 Billion by 2033 with 12.6% CAGR North America Leads wi …
The Global Femtech Market reached US$ 38.90 billion in 2024 and is projected to grow significantly to US$ 112.30 billion by 2033, registering a CAGR of 12.6% during the forecast period 2025-2033. This strong growth reflects increasing awareness of women's health issues, rising digital health adoption, and greater investments in technology-driven healthcare solutions tailored specifically for women.
Femtech focuses on addressing both female-specific and women-prevalent health conditions through products such as…
Precision Viticulture Market | US$ 9.51 Billion by 2032 | 14.40% CAGR | Europe L …
The Global Precision Viticulture Market reached US$ 3.24 billion in 2024 and is expected to reach US$ 9.51 billion by 2032, growing at a CAGR of 14.40% during the forecast period 2025-2032. Market growth is driven by the increasing adoption of advanced agricultural technologies to improve vineyard productivity, optimize resource utilization, and enhance grape quality amid rising climate variability.
Precision viticulture integrates technologies such as GPS, remote sensing, drones, IoT sensors,…
United States Public Safety and Security Market sees strong growth at a CAGR of …
The public safety and security market is projected to grow from USD 564.05 billion in 2025 to USD 979.84 billion by 2030 at a compound annual growth rate (CAGR) of 11.4% during the forecast period. The growing trend of IoT in public safety is driving the market as connected devices enable real-time monitoring, faster responses, and better management of emergencies. It helps authorities gather accurate data and improve decision-making. The…
More Releases for CMT
Komoot Partner Award 2025 honors Europe's strongest tourism campaigns at CMT Stu …
On January 19, 2026, komoot will present the most effective outdoor campaigns of the year 2025. New: Adventurer Jonas Deichmann as keynote speaker.
Stuttgart - Komoot is once again putting outstanding achievements in digital tourism marketing at the center of attention at the international trade fair CMT Stuttgart. As part of the komoot Partner Awards, campaigns that have performed particularly well on the platform will be honored. The criteria for the…
Charcot-Marie-Tooth (CMT) Market Growth Drivers, Challenges, and Competitive Lan …
Charcot-Marie-Tooth (CMT) disease is one of the most common inherited neurological disorders, affecting approximately 1 in 2,500 people worldwide. CMT is a group of disorders that damage the peripheral nerves, which control muscles and relay sensory information. The condition results in muscle weakness, sensory loss, and deformities in the limbs, particularly in the feet, legs, and hands. CMT is caused by genetic mutations affecting proteins responsible for nerve function and…
Carboxymethyl Tamarind Gum (CMT) Market Expansion Report 2025: Effective Strateg …
The global market for Carboxymethyl Tamarind Gum (CMT) was estimated to be worth US$ 17.8 million in 2024 and is forecast to a readjusted size of US$ 26.9 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Global Leading Market Research Publisher QYResearch announces the release of its lastest report "Carboxymethyl Tamarind Gum (CMT) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based…
Carboxymethyl Tamarind Gum (CMT) Market: Manufacturer Capacity, Output, Sales, C …
"Global Carboxymethyl Tamarind Gum (CMT) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031" is published by Global Info Research. It covers the key influencing factors of the Carboxymethyl Tamarind Gum (CMT) market, including Carboxymethyl Tamarind Gum (CMT) market share, price analysis, competitive landscape, market dynamics, consumer behavior, and technological impact, etc.At the same time, comprehensive data analysis is conducted by national and regional sales, corporate competition rankings,…
Quasar Markets Welcomes Financial Industry Leader Tyler Wood, CMT to Board
Image: https://www.getnews.info/wp-content/uploads/2024/07/1720025222.jpeg
Tyler Wood, CMT, joins Quasar Markets board, bringing expertise in financial services and educational technology.
July 3, 2024 - New York, NY - Quasar Markets, a pioneer in AI-powered financial market research solutions, is thrilled to announce the appointment of Tyler Wood, CMT to its Board of Directors. With a rich history in educational technology and financial services, Tyler's extensive experience and innovative mindset are set to propel Quasar Markets…
Construction Materials Testing (CMT) Market Type, Application, Demands, Growth R …
Construction Materials Testing (CMT) Market survey offers key information about the industry, helpful and important facts and figures, expert opinions, and the latest developments across the world. The report includes data on patterns and improvements, target business sectors and materials, limits, and advancements. This market report is a valuable document for every market enthusiast, policymaker, investor, and market player. This report encompasses a chapter on the global Construction Materials Testing…
